Skip to main content
. 2021 Sep 15;13(9):1472. doi: 10.3390/pharmaceutics13091472

Table 4.

Physical characterization of pDNA-based vectors.

Size (nm) PDI ζ-Potential (mV)
Plasmid pcDNA3-EGFP
pDNA-DX-SLNHM 94.5 ± 1.0 0.27 ± 0.00 +43.9 ± 1.01
pDNA-HA-SLNHM 204.0 ± 2.8 0.25 ± 0.01 +26.3 ± 0.1
Plasmid pUNO1-hIL10
pDNA-DX-SLNHM 101.1 ± 1.1 0.27 ± 0.00 +44.7 ± 0.6
pDNA-HA-SLNHM 193.7 ± 15.1 0.48 ± 0.01 +41.4 ± 0.2

DX: dextran; HA: hyaluronic acid; SLNEE: solid lipid nanoparticle prepared by emulsification-evaporation method. SLNHM: solid lipid nanoparticle prepared by hot-melt emulsification method. SLNC: solid lipid nanoparticle prepared by coacervation method. PDI: polydispersity index. Data are expressed as mean ± standard deviation; n = 3.